Rebound of background parenchymal enhancement post cessation of tamoxifen therapy

Breast J. 2021 Sep;27(9):735-736. doi: 10.1111/tbj.14275. Epub 2021 Aug 2.

Authors

Nicole Marie Sakla¹, Tej Phatak¹, Luke Partyka¹

Affiliation

¹ Newark Beth Israel Medical Center, The Breast Center, Newark, NJ, USA.

PMID: 34342066
DOI: 10.1111/tbj.14275

No abstract available

Keywords: antiestrogenic inhibition; background parenchymal enhancement; tamoxifen rebound.

MeSH terms

Breast Neoplasms* / drug therapy
Estrogen Antagonists
Female
Humans
Tamoxifen / adverse effects

Substances

Estrogen Antagonists
Tamoxifen